Bibliography
Export 8 results:
Filters: Keyword is Graft Rejection / prevention & control [Clear All Filters]
Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Transpl Infect Dis. 2010;12(2):151-4.
Breakthrough Fusarium spp fungemia during caspofungin therapy in an ABO-incompatible orthotopic liver transplant patient. J Chemother. 2009;21(2):236-8.
Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation. Liver Transpl. 2008;14(5):647-50.
Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation. Transpl Int. 2006;19(4):295-302.
Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. Am J Transplant. 2005;5(4 Pt 1):775-80.
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc. 2005;37(2):802-3.
De novo malignances in pediatric organ transplant recipients. Pediatr Transplant. 1998;2(1):56-63.
Inability of OKT3 to prevent donor-derived ABO hemolytic anemia in a kidney-pancreas transplant recipient. Transpl Int. 1995;8(2):159-60.